Sponsor:
Icahn School of Medicine at Mount Sinai
Code:
NCT05982925
Conditions
Multiple Sclerosis
Neuromyelitis Optica
Demyelinating Autoimmune Diseases, CNS
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Brief summary:
Conditions
Multiple Sclerosis
Neuromyelitis Optica
Demyelinating Autoimmune Diseases, CNS
Study ID
NCT05982925
Start date
May 6, 2022
Status verified date
Jun, 2026
Completion date
Jul 31, 2034
Anticipated
Primary completion date
Jul 31, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
170 participants
Anticipated
Arms
MS Participant
Control Participant
Other Neuroinflammatory Participants
Primary outcome measure
Central contacts
Locations
Mount Sinai Hospital
Recruiting
New York, New York, United States, 10029
Contacts
Principal Investigator:
Erin S Beck
Sponsor
Icahn School of Medicine at Mount Sinai
Last update posted
Jun 15, 2026
Last verified
Jun, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai on 2026-06-15.